It's not bad news for monepantel because monepantel does what rapamycin does but with less adverse effects: Monepantel represents the first of the next gen mTOR inhibitors and increasingly like rapamycin's/sirolimus's successor for a whole range of therapies - and that's no small thing !!!
However, agree with your point about the importance of marketing and the implication of getting good public info out there more generally. NZ Trader especially has been banging the drum on this for a long time. Things are already changing on this front with MT in a number of ways.
Cheers
- Forums
- ASX - By Stock
- FDA Application for Orphan Drug Designation , PAA, MPL
It's not bad news for monepantel because monepantel does what...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $111.9M |
Open | High | Low | Value | Volume |
21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 93524 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 71004 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 93524 | 0.225 |
9 | 434233 | 0.220 |
7 | 714363 | 0.215 |
5 | 342677 | 0.210 |
2 | 98485 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 71004 | 2 |
0.235 | 170709 | 3 |
0.240 | 214527 | 3 |
0.250 | 296054 | 5 |
0.260 | 410162 | 3 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online